ski-o-703
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02717988)
Timeline
Indications
Mechanism of action
- Tyrosine-protein kinase SYKINHIBITOR
SYK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ski-o-703
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05042986 | Early Phase 1 (Phase 1) | Aug 10, 2021 | Oscotec Inc. |
| NCT04056195 | Phase 2 | Sep 30, 2019 | Oscotec Inc. |
| NCT04057118 | Phase 2 | Mar 20, 2019 | Oscotec Inc. |
| NCT03315494 | Phase 1 | Sep 22, 2016 | Oscotec Inc., PPD |
| NCT02717988 | Phase 1 | Sep 1, 2015 | Oscotec Inc., PPD |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Oscotec Inc. | For profit | 5 | 5 | 2 | 2015 |
| PPD | For profit | 2 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1